1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Serum chemokines and cytokines in CLL patients treated with duvelisib, a PI3K-δ,γ inhibitor
    Meeting Abstract

    Douglas, M.; Allen, K.; Sweeney, J.; O'Brien, S. M.; Flinn, I.; Horwitz, S. M.; Byrd, J. C.; Patel, M. R.; Kahl, B. S.; Foss, F. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase III trial evaluating the addition of bevacizumab to letrozole as first-line endocrine therapy for treatment of hormone-receptor positive advanced breast cancer: CALGB 40503 (Alliance)
    Meeting Abstract

    Dickler, M. N.; Barry, W. T.; Cirrincione, C. T.; Ellis, M. J.; Moynahan, M. E.; Innocenti, F.; Hurria, A.; Rugo, H. S.; Lake, D.; Hahn, O. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Crossover in oncology clinical trials
    Meeting Abstract

    Diaz, J.; Sternberg, C. N.; Mehmud, F.; Delea, T. E.; Latimer, N.; Bartlett-Pandite, A. N.; Motzer, R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Influence of language barriers on hospital readmissions in cancer patients
    Meeting Abstract

    Diamond, L.; Gany, F.; Pottinger, T. D.; Samedy, P.; Dong, A.; Martin, S.; Korenstein, D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A randomized phase III study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced liposarcoma (LPS) or leiomyosarcoma (LMS)
    Meeting Abstract

    Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Staddon, A. P.; Milhem, M. M.; Elias, A. D.; Ganjoo, K. N.; Tawbi, H. A. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prognostic value of genomic signatures in metastatic clear cell renal cell carcinoma (mRCC) using The Cancer Genome Atlas (TCGA) data
    Meeting Abstract

    de Velasco, G.; Fay, A. P.; Culhane, A.; Hakimi, A. A.; Voss, M. H.; Tannir, N. M.; Tamboli, P.; Appleman, L. J.; Bellmunt, J.; Rathmell, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Evaluation of predictive biomarkers of response and prognosis in patients with high-grade extrapulmonary neuroendocrine carcinomas treated with platin-based chemotherapy
    Meeting Abstract

    Rego, J. F. D.; Medeiros, R. S. S.; Braghiroli, M. I. F. M.; Neto, J. E. B.; Munhoz, R. R.; Guerra, J. M.; Kimura, L.; Nonogaki, S.; Pfiffer, T. E. F.; Galvao, B.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • High-grade extrapulmonary neuroendocrine carcinomas and small cell lung cancer: Different entities, same treatment
    Meeting Abstract

    Rego, J. F. D.; Medeiros, R. S. S.; Braghiroli, M. I. F. M.; Galvao, B.; Neto, J. E. B.; Munhoz, R. R.; Guerra, J. M.; Kimura, L.; Nonogaki, S.; Pfiffer, T. E. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • LORELEI: A phase II randomized, double-blind study of neoadjuvant letrozole plus taselisib (GDC-0032) versus letrozole plus placebo in postmenopausal women with ER-positive/HER2-negative, early-stage breast cancer
    Meeting Abstract

    de Azambuja, E.; Saura, C.; Oliveira, M.; Dubsky, P. C.; Zardavas, D.; Fesl, C.; Bardia, A.; Lin, R.; Fredrickson, J. O.; Parmar, H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Performance of CCP assay in an updated series of biopsy samples obtained from commercial testing
    Meeting Abstract

    Davis, J. W.; Crawford, E. D.; Shore, N.; Scardino, P. T.; Tward, J. D.; Harrison, L.; Evans, B.; Fitzgerald, L.; Stone, S.; Brawer, M. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save